Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma





<br /> Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma – Fingerprint<br /> — Icahn School of Medicine at Mount Sinai


Physics & Astronomy

Medicine & Life Sciences

Chemical Compounds

Read more here: Source link